EcoDrugPlus


Trade Names	EQUIPIN HOMAPIN-10 HOMAPIN-5
Synonyms	Equipin Homapin Homapin-10 Homapin-5 Homatropine methylbromide Homatropini methylbromidum NSC-34399 NSC-757048
Status
Molecule Category	Salt
ATC	A03BB06
UNII	68JRS2HC1C
EPA CompTox	DTXSID4023127

Trade Names

EQUIPIN

HOMAPIN-10

HOMAPIN-5

Synonyms

Equipin

Homapin

Homapin-10

Homapin-5

Homatropine methylbromide

Homatropini methylbromidum

NSC-34399

NSC-757048

Status

Molecule Category

Salt

ATC

A03BB06

UNII

68JRS2HC1C

EPA CompTox

DTXSID4023127


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	FUFVKLQESJNNAN-RIMUKSHESA-M
Smiles	C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2.[Br-]
InChI	InChI=1S/C17H24NO3.BrH/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12;/h3-7,13-16,19H,8-11H2,1-2H3;1H/q+1;/p-1/t13-,14+,15+,16?;

InChI Key

FUFVKLQESJNNAN-RIMUKSHESA-M

Smiles

C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2.[Br-]

InChI

InChI=1S/C17H24NO3.BrH/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12;/h3-7,13-16,19H,8-11H2,1-2H3;1H/q+1;/p-1/t13-,14+,15+,16?;

Resources	Reference
ChEMBL	CHEMBL1200851
FDA SRS	68JRS2HC1C
SureChEMBL	SCHEMBL20659943

Resources

Reference

ChEMBL

CHEMBL1200851

FDA SRS

68JRS2HC1C

SureChEMBL

SCHEMBL20659943


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

HOMATROPINE METHYLBROMIDE

Structure

Cross References